2026年全球基因組癌症檢測與分析市場報告

近年來，基因組癌症檢測和分析市場經歷了顯著成長，預計將從2025年的102.8億美元成長到2026年的111.7億美元，複合年成長率（CAGR）為8.7%。過去幾年的成長可歸因於癌症發生率的上升、定序技術的進步、腫瘤診斷的擴展、基因組研究經費的增加以及精準醫療的日益普及。

預計未來幾年，基因組癌症檢測和分析市場將保持強勁成長，到2030年市場規模將達到154.5億美元，複合年成長率（CAGR）為8.4%。預測期內的成長主要歸功於伴隨診斷的擴展、液態生物檢體技術的日益普及、人工智慧在基因組分析中的應用、腫瘤篩檢計畫的增加以及經濟高效的定序平台的開發。預測期內的關鍵趨勢包括：多基因癌症檢測的廣泛應用、次世代定序的普及、液態生物檢體檢測的廣泛應用、對個人化癌症治療需求的成長以及基因組數據在臨床決策中的整合。

癌症發生率的不斷上升預計將推動未來基因組癌症檢測和分析市場的成長。癌症是一種異常細胞在體內不受控制地生長和擴散的疾病。癌症發生率的上升歸因於人口老化，預期壽命的延長增加了癌症的風險。基因組癌症檢測和分析透過識別基因突變和生物標記來輔助腫瘤治療，從而實現個人化治療方案，並改善早期檢測和疾病監測。例如，根據美國非營利組織美國癌症協會統計，截至2024年1月，2022年全球報告的新增癌症病例約2000萬例，死亡病例約970萬例。主要受人口成長的驅動，預計2050年，全球癌症負擔將達到3,500萬例。因此，癌症發生率的上升正在推動基因組癌症檢測和分析市場的成長。

在基因組癌症檢測和分析市場中，主要企業正致力於次世代定序儀等技術創新，以提高癌症診斷的準確性、速度和深度，並支援更個人化的治療決策。次世代定序儀是一種先進的DNA測序技術，能夠快速、高通量地進行基因分析，以檢測基因突變、變異和其他基因組特徵。例如，總部位於荷蘭的生物技術公司QIAGEN NV於2025年4月發布了專為次世代定序儀開發的QIAseq檢測板。此檢測板能夠分析700多個基因，從而實現全面的基因組分析。這些檢測板旨在用於研究和臨床，以期改善癌症的診斷和治療方法。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球基因組癌症檢測與分析市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧（AI）和自主人工智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 多基因癌症檢測組合的應用日益廣泛
  • 擴大次世代定序的應用
  • 液態生物檢體檢測的擴展
  • 對個人化癌症治療的需求日益成長
  • 將基因組數據整合到臨床決策中

第5章 終端用戶產業市場分析

• 醫院
• 臨床和診斷檢查室
• 研究和學術機構
• 腫瘤中心
• 生技公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球基因組癌症檢測和分析市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球基因組癌症檢測及分析市場規模、對比及成長率分析
• 全球基因組癌症檢測與分析市場表現：規模與成長，2020-2025年
• 全球基因組癌症檢測與分析市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 透過組織檢查
• 固態組織檢查，液體組織檢查
• 透過技術
• 次世代定序（NGS）、聚合酵素鏈鎖反應（PCR）、螢光原位雜合反應（FISH）、免疫組織化學（IHC）及其他技術
• 按癌症類型分組
• 單基因檢測板、多基因檢測板
• 透過使用
• 臨床和研究
• 最終用戶
• 醫院、研究和學術機構、臨床和診斷檢查室以及其他最終用戶
• 按類型細分：固態組織偵測
• 切片檢查樣本、手術切除樣本、福馬林固定石蠟包埋（FFPE）組織、冷凍組織
• 按類型細分：液體組織檢測
• 血液、尿液、唾液、腦脊髓液和其他體液

第10章 區域與國家分析

• 全球基因組癌症檢測及分析市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球基因組癌症檢測及分析市場：依國家/地區、市場表現及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 基因組癌症檢測和分析市場：競爭格局和市場佔有率，2024 年
• 基因組癌症檢測與分析市場：公司估值矩陣
• 基因組癌症檢測及分析市場：公司概況
  • Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Hologic Inc.
  • Illumina Inc.

第37章：其他領先和創新企業

• Sysmex Corporation, QIAGEN NV, Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年基因組癌症檢測與分析市場：提供新機會的國家
• 2030年基因組癌症檢測與分析市場：提供新機會的細分市場
• 2030年基因組癌症檢測與分析市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Genomic cancer panel and profiling is a molecular diagnostic approach that examines multiple genes at the same time to identify genetic mutations, alterations, or biomarkers linked to cancer. Its main objective is to support personalized treatment decisions, predict disease progression, and enhance cancer diagnosis and monitoring.

The main tissue testing types in genomic cancer panel and profiling include solid tissue testing and liquid tissue testing. Solid tissue testing involves analyzing samples obtained from solid tumors or organs to detect genetic mutations, biomarkers, or disease-specific characteristics. This process utilizes technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and others, and includes both single-gene and multi-gene cancer panels. These tests are applied in clinical and research settings and are used by hospitals, research and academic institutes, clinical and diagnostic laboratories, and other end users.

Tariffs have affected the genomic cancer panel and profiling market by increasing the cost of imported sequencing instruments, reagents, and diagnostic consumables. These impacts have been most significant in hospital and diagnostic laboratory segments in North America and Europe. Asia-Pacific regions have experienced cost pressures due to reliance on imported genomic technologies. However, tariffs have encouraged local manufacturing of diagnostic kits and strengthened regional genomic testing capabilities.

The genomic cancer panel and profiling market research report is one of a series of new reports from The Business Research Company that provides genomic cancer panel and profiling market statistics, including genomic cancer panel and profiling industry global market size, regional shares, competitors with a genomic cancer panel and profiling market share, detailed genomic cancer panel and profiling market segments, market trends and opportunities, and any further data you may need to thrive in the genomic cancer panel and profiling industry. This genomic cancer panel and profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomic cancer panel and profiling market size has grown strongly in recent years. It will grow from $10.28 billion in 2025 to $11.17 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growth in cancer prevalence, advancement in sequencing technologies, expansion of oncology diagnostics, increased funding for genomic research, rising adoption of precision medicine.

The genomic cancer panel and profiling market size is expected to see strong growth in the next few years. It will grow to $15.45 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to expansion of companion diagnostics, growth in liquid biopsy adoption, integration of ai in genomic analysis, increasing oncology screening programs, development of cost-effective sequencing platforms. Major trends in the forecast period include increasing adoption of multi-gene cancer panels, rising use of next-generation sequencing, expansion of liquid biopsy testing, growing demand for personalized oncology, integration of genomic data in clinical decision-making.

The increasing incidence of cancer is expected to drive the growth of the genomic cancer panel and profiling market going forward. Cancer is a disease marked by the uncontrolled growth and spread of abnormal cells in the body. The rise in cancer incidence is attributed to an aging population, as longer life expectancy increases the likelihood of developing cancer. Genomic cancer panels and profiling aid oncology care by identifying genetic mutations and biomarkers, enabling personalized treatment approaches, and improving early detection and disease monitoring. For instance, in January 2024, according to the American Cancer Society, a U.S.-based nonprofit organization, in 2022, approximately 20 million new cancer cases were reported worldwide, resulting in 9.7 million deaths; driven mainly by population growth, the global cancer burden is projected to reach 35 million cases by 2050. Therefore, the rising incidence of cancer is driving the growth of the genomic cancer panel and profiling market.

Major companies operating in the genomic cancer panel and profiling market are concentrating on technological advancements such as next-generation sequencers to enhance the accuracy, speed, and depth of cancer diagnostics and support more personalized treatment decisions. Next-generation sequencers are advanced DNA sequencing technologies that allow rapid, high-throughput analysis of genetic material to detect mutations, variations, and other genomic characteristics. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq panels developed for next-generation sequencers, enabling comprehensive genomic profiling through the analysis of more than 700 genes. These panels are designed for both research and clinical use, with the objective of improving cancer diagnostics and treatment approaches.

In June 2023, Quest Diagnostics, a US-based clinical laboratory company, acquired Haystack Oncology for an undisclosed amount. Through this acquisition, Quest Diagnostics expanded its capabilities in liquid biopsy and cancer detection, strengthening its genomic testing portfolio. Haystack Oncology is a US-based biotechnology company focused on developing innovative liquid biopsy technologies for early cancer detection and disease monitoring.

Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.

North America was the largest region in the genomic cancer panel and profiling market in 2025. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomic cancer panel and profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomic cancer panel and profiling market consists of revenues earned by entities by providing services such as genetic mutation analysis, companion diagnostic testing, cancer risk assessment, and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic cancer panel and profiling market also includes sales of targeted gene panels, companion diagnostic kits, sequencing platforms and instruments, bioinformatics software, and analysis tools. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomic Cancer Panel And Profiling Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses genomic cancer panel and profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomic cancer panel and profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genomic cancer panel and profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Tissue Testing: Solid Tissue Testing; Liquid Tissue Testing
• 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Fluorescence In-Situ Hybridization (FISH); Immunohistochemistry (IHC); Other Technologies
• 3) By Cancer Panel Type: Single-Gene Panel; Multi-Gene Panel
• 4) By Application: Clinical; Research
• 5) By End User: Hospitals; Research And Academic Institutes; Clinical And Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Solid Tissue Testing: Biopsy Samples; Surgical Resection Samples; Formalin-Fixed Paraffin-Embedded (FFPE) Tissues; Fresh Frozen Tissues
• 2) By Liquid Tissue Testing: Blood; Urine; Saliva; Cerebrospinal Fluid (CSF); Other Bodily Fluids
• Companies Mentioned: Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.; Sysmex Corporation; QIAGEN N.V.; Exact Sciences Corporation; ARUP Laboratories; Tempus Labs; Genscript Biotech Corporation; NeoGenomics Inc.; Foundation Medicine; Invitae Corporation; Guardant Health Inc.; Caris Life Sciences; Fulgent Genetics; NanoString Technologies Inc.; Genecast Biotechnology Co. Ltd; Burning Rock DX; HTG Molecular Diagnostics Inc.; Predictive Oncology Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Genomic Cancer Panel And Profiling Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Genomic Cancer Panel And Profiling Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Genomic Cancer Panel And Profiling Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Genomic Cancer Panel And Profiling Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Multi-Gene Cancer Panels
  • 4.2.2 Rising Use Of Next-Generation Sequencing
  • 4.2.3 Expansion Of Liquid Biopsy Testing
  • 4.2.4 Growing Demand For Personalized Oncology
  • 4.2.5 Integration Of Genomic Data In Clinical Decision-Making

5. Genomic Cancer Panel And Profiling Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinical And Diagnostic Laboratories
• 5.3 Research And Academic Institutes
• 5.4 Oncology Centers
• 5.5 Biotechnology Companies

6. Genomic Cancer Panel And Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Genomic Cancer Panel And Profiling Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Genomic Cancer Panel And Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Genomic Cancer Panel And Profiling Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Genomic Cancer Panel And Profiling Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Genomic Cancer Panel And Profiling Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Genomic Cancer Panel And Profiling Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Genomic Cancer Panel And Profiling Market Segmentation

• 9.1. Global Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Solid Tissue Testing, Liquid Tissue Testing
• 9.2. Global Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
• 9.3. Global Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single-Gene Panel, Multi-Gene Panel
• 9.4. Global Genomic Cancer Panel And Profiling Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical, Research
• 9.5. Global Genomic Cancer Panel And Profiling Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users
• 9.6. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Solid Tissue Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
• 9.7. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Liquid Tissue Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids

10. Genomic Cancer Panel And Profiling Market Regional And Country Analysis

• 10.1. Global Genomic Cancer Panel And Profiling Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Genomic Cancer Panel And Profiling Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Genomic Cancer Panel And Profiling Market

• 11.1. Asia-Pacific Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Genomic Cancer Panel And Profiling Market

• 12.1. China Genomic Cancer Panel And Profiling Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Genomic Cancer Panel And Profiling Market

• 13.1. India Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Genomic Cancer Panel And Profiling Market

• 14.1. Japan Genomic Cancer Panel And Profiling Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Genomic Cancer Panel And Profiling Market

• 15.1. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Genomic Cancer Panel And Profiling Market

• 16.1. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Genomic Cancer Panel And Profiling Market

• 17.1. South Korea Genomic Cancer Panel And Profiling Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Genomic Cancer Panel And Profiling Market

• 18.1. Taiwan Genomic Cancer Panel And Profiling Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Genomic Cancer Panel And Profiling Market

• 19.1. South East Asia Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Genomic Cancer Panel And Profiling Market

• 20.1. Western Europe Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Genomic Cancer Panel And Profiling Market

• 21.1. UK Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Genomic Cancer Panel And Profiling Market

• 22.1. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Genomic Cancer Panel And Profiling Market

• 23.1. France Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Genomic Cancer Panel And Profiling Market

• 24.1. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Genomic Cancer Panel And Profiling Market

• 25.1. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Genomic Cancer Panel And Profiling Market

• 26.1. Eastern Europe Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Genomic Cancer Panel And Profiling Market

• 27.1. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Genomic Cancer Panel And Profiling Market

• 28.1. North America Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Genomic Cancer Panel And Profiling Market

• 29.1. USA Genomic Cancer Panel And Profiling Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Genomic Cancer Panel And Profiling Market

• 30.1. Canada Genomic Cancer Panel And Profiling Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Genomic Cancer Panel And Profiling Market

• 31.1. South America Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Genomic Cancer Panel And Profiling Market

• 32.1. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Genomic Cancer Panel And Profiling Market

• 33.1. Middle East Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Genomic Cancer Panel And Profiling Market

• 34.1. Africa Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Segmentation By Technology, Segmentation By Cancer Panel Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Genomic Cancer Panel And Profiling Market Regulatory and Investment Landscape

36. Genomic Cancer Panel And Profiling Market Competitive Landscape And Company Profiles

• 36.1. Genomic Cancer Panel And Profiling Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Genomic Cancer Panel And Profiling Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Genomic Cancer Panel And Profiling Market Company Profiles
  • 36.3.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Genomic Cancer Panel And Profiling Market Other Major And Innovative Companies

• Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX

38. Global Genomic Cancer Panel And Profiling Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Genomic Cancer Panel And Profiling Market

40. Genomic Cancer Panel And Profiling Market High Potential Countries, Segments and Strategies

• 40.1 Genomic Cancer Panel And Profiling Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Genomic Cancer Panel And Profiling Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Genomic Cancer Panel And Profiling Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer